ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis

INTRODUCTION: No clinically useful predictive factor has been yet identified for treatment of metastatic pancreatic cancer (mPC). It is noteworthy that FOLFIRINOX, despite its high toxicity, is effective only in some patients. We retrospectively analyzed expression of excision repair cross-complemen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Strippoli, Antonia, Rossi, Sabrina, Martini, Maurizio, Basso, Michele, D'Argento, Ettore, Schinzari, Giovanni, Barile, Rosalba, Cassano, Alessandra, Barone, Carlo
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5085217/
https://ncbi.nlm.nih.gov/pubmed/27147577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9063
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky